Thank you for subscribing!
Finfeed Archived Sep 19, 2019
New antibodies for the key lead biomarker used in Rhythm Biosciences' (ASX: RHY) ColoSTAT® test can successfully differentiate between cancer and healthy samples, and the test has now been optimised.
Finfeed Archived Sep 11, 2019
The S&P/ASX 200 Healthcare Sector blitzed the rest of the market, increasing 12.7% against the ASX 200 which interestingly by the start of September was already back in positive territory, up 4.5%.
Finfeed Archived Sep 09, 2019
Imagion Biosystems (ASX:IBX) advised the market of early-stage evidence that the technology could have applications in improving magnetic resonance imaging (MRIs).
Finfeed Archived Sep 04, 2019
Immuron’s (ASX:IMC) share price has surged on the back of extremely promising clinical results.
Get expert stock analysis direct in your inbox
Finfeed Archived Aug 08, 2019
The estimated present value of benefits from the CSIRO’s work is around $3.2 billion per year, so it's no surprise that the CSIRO and the rather astute BioScience Managers would eventually cross paths.
Finfeed Archived Jul 11, 2019
Rhinomed Ltd (ASX:RNO), are leaders in airway technology and the developers of the Mute nasal stent, the fastest growing product in the nasal strip category in US based drug stores.
Finfeed Archived Jul 08, 2019
Leading distributor and manufacturer of branded premium health and natural beauty products, Star Combo Pharma Ltd (ASX:S66) has made a transformational acquisition of Bio-e.
Finfeed Archived May 20, 2019
Alcidion Group (ASX:ALC) will build and integrate two key components for a proposed national Child Digital Health Record (CDHR), thanks to a new contract with NSW Health.
Finfeed Archived Apr 15, 2019
Immuron Limited (ASX:IMC | NASDAQ:IMRN) third quarter sales for its commercially available products, including Travelan®, surged 66%.
Join Our Mailing List
